No Data
TNF Pharmaceuticals, Renova Health Announce Trial to Explore Isomyosamine
Express News | TNF Pharmaceuticals Enters Collaborative Agreement With Renova Health For A Planned Trial Of Its TNF-α Inhibitor Drug Isomyosamine
RENOVA Reports November Electricity Sales, Output Curtailment Impact
Automa Amplía Sus Operaciones En El Mercado Energético Europeo
BNP Paribas Exane Downgrades EDP Renováveis to Underperform, Cuts PT
Iida GHD, Toyo, etc. (additional) Rating
Upgrade - Bullish code stock name securities company traditional change after -------------------------------------------------- <9983> FirstLiteiJPM "Neutral" "OverW" Downgrade - Bearish code stock name securities company traditional change after -------------------------------------------------- <